2026 Healthcare Investment Trends: PwC

Inpatient care continues to rely heavily on psychiatric hospitals, with nearly half of admissions occurring involuntarily and over 20% lasting longer than a year. Importantly, this early‑stage vibrancy is now being matched by activity at the later‑stage end of the women’s health market. The $18.3 billion take‑private of Hologic by Blackstone and TPG completed on 7 April marks a significant milestone, signalling that investors see long‑term strategic value in women’s health portfolios.

Explore M&A trend reports by industry

• At the conference, Nvidia and Eli Lilly announced a landmark partnership to build an AI drug discovery lab intended to unite top talent in the fields of pharmaceutical research and computer science.
• The practice, dubbed 'recommendation poisoning,' involves creating content specifically designed to appear authoritative to AI systems while promoting particular products or services.
• His story illustrates how AI tools have become compelling enough to re-engage even those who deliberately stepped away from technology.
• This and other information can be found in the Funds' prospectuses or, if available, the summary prospectuses, which may be obtained by visiting the iShares Fund and BlackRock Fund prospectus pages.
• Inflation declined, leading to an anticipation of interest rate cuts by the US Federal Reserve that then began with a large, 50-basis-point reduction in September.

As the U.S. population ages, addressing the complex mental health needs of seniors is rapidly shifting from a niche social concern to a central pillar of healthcare policy. For decades, geriatric mental health https://theasu.ca/blog/understanding-the-importance-of-health-education-in-nursing-a-comprehensive-guide-to-promoting-wellness-and-preventing-disease was a fragmented, marginalized sub-sector of the broader healthcare market. The intersection of an aging population, rising clinical acuity, and major regulatory catalysts have driven senior mental health care into a centralized focal point of investment activity. Investors have a unique opportunity to capitalize on the transition from fragmented, facility-based care to integrated, technology-enabled, and differentiated care delivery models.

Services to meet your business goals

Exploring three companies across the different layers of the AI tech stack including infrastructure, intelligence, and agents. Learn how systematic investing combines AI, quantitative analysis, and human expertise to power growth ETFs and other portfolio outcomes. Explore the latest investment themes in AI and geopolitics through the lens of thematic investing in our 2025 mid-year update. Discover how infrastructure investments may generate income, offer inflation hedging, and diversification.

Healthcare Investment Trends

The Contents have been prepared without regard to the investment objectives, financial situation, or means of any person or entity, and the Website is not soliciting any action based upon https://dynamicchiropractic.ca/articles/important-information-about-national-chiropractic-day-mark-your-calendars-and-join-the-celebration them. With a healthcare specialization, our teams bring both transactional and operational experience, delivering meaningful results and creating value. The surge in investment in administrative AI is beginning to have spillover impacts into the clinical realm.

This policy  is accompanied by wider shifts in investor sentiment, signalling that FemTech is not a niche category but a strategic opportunity. Ambulatory and post-acute services are expected to drive healthcare sector volume growth in 2026, fueled by cost pressures, an aging population, advances in therapy and value-based care. Medtech companies remain focused on sharpening their portfolios through divesting lower-growth or non-core assets and reinvesting in faster-growing categories. In 2025, BD’s announced sale of its advanced bioprocessing business and certain diagnostics assets to Waters Corporation for approximately $17.5bn exemplified this trend. Similar moves are underway across the sector, including carveouts in diabetes, surgical, and patient monitoring businesses, as companies concentrate on core platforms. As more financial investors approach the end of holding periods, we expect a steady pipeline of divestitures and secondary transactions.

• Current patch cycles and response processes weren't designed for this environment, requiring organizations to build 'Mythos-ready' security programs that can respond at machine speed rather than human timescales.
• The debate over drug pricing is increasingly shaped by policy proposals like Most Favored Nation (MFN), which would peg U.S. reimbursement to the lowest prices paid globally.
• Managing benefit costs proactively will be a key opportunity in the healthcare sector in 2026, as surging costs continue to erode the capital available for strategic investment.
• There is continued growth of elaborate Hub services, and pharmacies and pharmacy supply chains themselves are increasingly valuable to those accessing both rare and high-cost drugs, with a growing need for more efficient, advanced technologies.
• One of the topics that Radner referenced was really China is one of the major driving sources of innovation.

Other Financial Buyer Transactions Closed

Chinese government incentives and returnee scientists have driven an investment boom in Chinese biotech in the last several years, which has created an attractive ecosystem for drug developers that need resources and facilities to advance their proofs of concept. Global pharma companies see China as a way to fast-track innovation, setting up future pipelines in areas such as oncology, diabetes and immunology and hedging against patent expirations. Annual revenue from drugs originating in China could soar to $34 billion by 2030 and $220 billion by 2040, according to Morgan Stanley Research. Conversations at Morgan Stanley’s 23rd Annual Global Healthcare Conference underscored that innovation remains a focus for companies in areas such as neurology, oncology and immunology, as well as the integration of AI and partnerships or strategic M&A between companies. © 2026 KPMG LLP, a Delaware limited liability partnership, and its subsidiaries are part of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work.